The press releases contained in this section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. Medicis has no obligation to update any information contained in such press releases after the date of their issuance. For current information about the Company, please refer to our most recent public filings with the Securities and Exchange Commission.

Receive all Medicis news via e-mail

View the Medicis News Archive

Fiscal Year 2005 News Archive
Jun 15, 2005
Medicis Declares Cash Dividend
Jun 9, 2005
Medicis to Present at Thomas Weisel Partners Growth Forum 7.0
May 19, 2005
Medicis to Present at UBS Global Pharmaceuticals Conference
May 6, 2005
Medicis and Inamed Receive Hart-Scott-Rodino Request for Additional Information
May 2, 2005
Medicis to Present at Morgan Stanley 3rd Annual Healthcare Unplugged Conference
Apr 29, 2005
Medicis to Present at Deutsche Bank 30th Annual Health Care Conference
Apr 20, 2005
Medicis Reports Third Quarter Fiscal 2005 Financial Results
Apr 18, 2005
Medicis Announces Third Quarter Fiscal 2005 Conference Call and Webcast
Mar 21, 2005
Medicis and Inamed Agree to Merge; Combination Will Create A Global Leader in Aesthetics Products and Dermatological Medicine With Annual Revenue in Excess of $700 Million
Mar 16, 2005
Medicis Declares Cash Dividend
Mar 2, 2005
Medicis Announces the Launch of Restylane Rewards - First-Ever Consumer Loyalty Program for a Cosmetic Procedure
Feb 18, 2005
Medicis Announces FDA Approval of AMMONUL for Urea Cycle Disorder
Feb 14, 2005
Medicis Announces FDA Approval of Its NDA for VANOS, a Patented Class I Corticosteroid for Plaque-Type Psoriasis
Feb 7, 2005
Medicis to Present at Merrill Lynch 16th Annual Global Pharmaceutical, Biotechnology & Medical Device Conference
Jan 28, 2005
Medicis Amends Strategic Alliance with aaiPharma
Jan 26, 2005
Supermodel Frederique van der Wal Signs on as the New Face of Restylane
Jan 20, 2005
Medicis Reports Second Quarter Fiscal 2005 Financial Results; 31% Increase in Revenues and 50% Increase in Earnings Per Share, Absent Special Charges
Jan 17, 2005
Medicis Announces Second Quarter Fiscal 2005 Conference Call and Webcast
Jan 12, 2005
Medicis and BioMarin Reach Settlement
Jan 6, 2005
Medicis to Present at 23rd Annual JPMorgan Healthcare Conference
Dec 30, 2004
Medicis to Present at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
Dec 14, 2004
Medicis Licenses Proprietary Peptide Technology from Ansata Therapeutics
Dec 14, 2004
Medicis Declares Cash Dividend
Nov 3, 2004
Medicis to Present at CIBC World Markets 15th Annual Healthcare Conference
Oct 29, 2004
Company Profile for Medicis
Oct 19, 2004
Medicis Reports First Quarter Fiscal 2005 Financial Results
Oct 19, 2004
Restylane Honored with Allure Magazine's 'Best of Beauty' Breakthrough Award
Oct 14, 2004
Medicis Announces First Quarter Fiscal 2005 Conference Call and Webcast
Sep 23, 2004
Medicis to Present at UBS Global Life Sciences Conference
Sep 14, 2004
Medicis Declares Cash Dividend
Sep 2, 2004
Medicis to Present at Thomas Weisel Partners Healthcare Tailwinds 2004 Conference
Aug 24, 2004
Medicis Reports Fourth Quarter and Year-End Fiscal 2004 Financial Results
Aug 19, 2004
Medicis Announces Fiscal 2004 Fourth Quarter and Year-End Conference Call and Webcast
Jul 15, 2004
Medicis Licenses SubQ from Q-Med


© 1996-2008 Medicis Pharmaceutical Corp